Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R 848
2. R-848
3. R848 Compound
1. 144875-48-9
2. R-848
3. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol
4. 1-[4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
5. Resiquimod [inn]
6. R 848
7. Resiquimod (r-848)
8. R848
9. S 28463
10. S-28463
11. V3dmu7pvxf
12. Mfcd00937759
13. Chembl383322
14. Chebi:36706
15. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
16. Cd11301
17. Cd-11301
18. R848;s28463
19. 2252319-44-9
20. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol.
21. 1h-imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-
22. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
23. R848 Compound
24. Unii-v3dmu7pvxf
25. 1h-imidazo(4,5-c)quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-
26. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol
27. Resiquimodr848
28. Vml-600
29. Rx8
30. R848; Resiquimod
31. S28463
32. Resiquimod [mi]
33. Resiquimod [usan]
34. Resiquimod [mart.]
35. Resiquimod [who-dd]
36. Schembl34159
37. Mls006010212
38. Alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol
39. Gtpl5051
40. Dtxsid7040603
41. Resiquimod, >=98% (hplc)
42. Hms3740o09
43. Bcp09103
44. Ex-a1879
45. Bdbm50241029
46. S8133
47. Zinc28572103
48. Akos016003509
49. Ccg-267635
50. Cs-1706
51. Db06530
52. Sb17111
53. 1-(4-amino-2-ethoxymethyl-imidazo[4,5-c]quinolin-1-yl)-2-methyl-propan-2-ol
54. Ncgc00370784-01
55. Ncgc00370784-05
56. Ac-35716
57. As-30885
58. Hy-13740
59. Smr002530531
60. Sy107476
61. Ft-0763049
62. R0197
63. Resiquimod, Vml-600, R-848, S-28463
64. A856222
65. Q426054
66. Sr-01000944954
67. J-008020
68. Sr-01000944954-1
69. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methyl-propan-2-ol
70. 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
71. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinolin-1-ethanol
72. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
| Molecular Weight | 314.4 g/mol |
|---|---|
| Molecular Formula | C17H22N4O2 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 314.17427596 g/mol |
| Monoisotopic Mass | 314.17427596 g/mol |
| Topological Polar Surface Area | 86.2 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 406 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in genital herpes.
Resiquimod is a Toll-like receptor 7 (TLR7) and TLR8 agonist that is a potent inducer of alpha interferon (IFN-alpha) and other cytokines.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Resiquimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Resiquimod, including repackagers and relabelers. The FDA regulates Resiquimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Resiquimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Resiquimod supplier is an individual or a company that provides Resiquimod active pharmaceutical ingredient (API) or Resiquimod finished formulations upon request. The Resiquimod suppliers may include Resiquimod API manufacturers, exporters, distributors and traders.
click here to find a list of Resiquimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Resiquimod DMF (Drug Master File) is a document detailing the whole manufacturing process of Resiquimod active pharmaceutical ingredient (API) in detail. Different forms of Resiquimod DMFs exist exist since differing nations have different regulations, such as Resiquimod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Resiquimod DMF submitted to regulatory agencies in the US is known as a USDMF. Resiquimod USDMF includes data on Resiquimod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Resiquimod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Resiquimod suppliers with USDMF on PharmaCompass.
Resiquimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Resiquimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Resiquimod GMP manufacturer or Resiquimod GMP API supplier for your needs.
A Resiquimod CoA (Certificate of Analysis) is a formal document that attests to Resiquimod's compliance with Resiquimod specifications and serves as a tool for batch-level quality control.
Resiquimod CoA mostly includes findings from lab analyses of a specific batch. For each Resiquimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Resiquimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Resiquimod EP), Resiquimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Resiquimod USP).
LOOKING FOR A SUPPLIER?
